Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingting Qiu

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Lupus Science & Medicine|May 30, 2023
Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLEEllen M Cody, Bridget E Wilson, Ekemini A Ogbu, et al.
Rheumatology (Oxford, England)|April 2, 2023
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same wayMaria Backström, Maarit Tarkiainen, Beth S Gottlieb, et al.
Pediatric Nephrology (Berlin, Germany)|January 30, 2023
Urine biomarker score captures response to induction therapy with lupus nephritisEllen M Cody, Scott E Wenderfer, Kathleen E Sullivan, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 21, 2019
Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet induced obesity and insulin resistanceGuohua Song, Chuanlong Zong, Mingzhu Shao, et al.
Scientific Reports|April 15, 2025
Validation of a novel CT perfusion software compared to RAPID in stroke patients receiving endovascular therapyDan Chen, Wenhuo Chen, Thanh N Nguyen, et al.
Oncology Reports|April 23, 2020
TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host diseaseFeng Zhu, Tingting Qiu, Shengyun Zhu, et al.
American Journal of Hematology|August 28, 2024
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapyYuekun Qi, Hujun Li, Kunming Qi, et al.
The Lancet. Haematology|July 26, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trialDian Zhou, Qian Sun, Jieyun Xia, et al.
Blood|May 21, 2026
Anti-BCMA/GPRC5D CAR T in relapsed or refractory multiple myeloma patients with extraosseous extramedullary diseaseDian Zhou, Yuekun Qi, Sha Ma, et al.
Blood|March 16, 2025
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myelomaSha Ma, Jieyun Xia, Miao Zhang, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Lupus Science & Medicine|May 30, 2023
Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLEEllen M Cody, Bridget E Wilson, Ekemini A Ogbu, et al.
Rheumatology (Oxford, England)|April 2, 2023
Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same wayMaria Backström, Maarit Tarkiainen, Beth S Gottlieb, et al.
Pediatric Nephrology (Berlin, Germany)|January 30, 2023
Urine biomarker score captures response to induction therapy with lupus nephritisEllen M Cody, Scott E Wenderfer, Kathleen E Sullivan, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|June 21, 2019
Phospholipid transfer protein (PLTP) deficiency attenuates high fat diet induced obesity and insulin resistanceGuohua Song, Chuanlong Zong, Mingzhu Shao, et al.
Scientific Reports|April 15, 2025
Validation of a novel CT perfusion software compared to RAPID in stroke patients receiving endovascular therapyDan Chen, Wenhuo Chen, Thanh N Nguyen, et al.
Oncology Reports|April 23, 2020
TIRC7 inhibits Th1 cells by upregulating the expression of CTLA‑4 and STAT3 in mice with acute graft‑versus‑host diseaseFeng Zhu, Tingting Qiu, Shengyun Zhu, et al.
American Journal of Hematology|August 28, 2024
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapyYuekun Qi, Hujun Li, Kunming Qi, et al.
The Lancet. Haematology|July 26, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trialDian Zhou, Qian Sun, Jieyun Xia, et al.
Blood|May 21, 2026
Anti-BCMA/GPRC5D CAR T in relapsed or refractory multiple myeloma patients with extraosseous extramedullary diseaseDian Zhou, Yuekun Qi, Sha Ma, et al.
Blood|March 16, 2025
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myelomaSha Ma, Jieyun Xia, Miao Zhang, et al.
Pageof 12